Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
November 08, 2016 11:00 PM

Trump presidency could bode well for pharma, devicemakers

Adam Rubenfire
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Stephen Ubl

    Drug and device makers welcomed the results of a general election expected to significantly impact their industry, even though the president-elect's stances are sometimes at odds with their own.

    Throughout his campaign, Republican Donald Trump stressed the need to curb rising drug prices and vowed to repeal the controversial 2.3% medical-device tax that was enacted in 2010 under the Affordable Care Act. He has spoken less about changes to the Food and Drug Administration's approval processes, but a law similar to the 21st Century Cures Act intended to speed up approvals is more likely to pass under a Republican-controlled Congress and White House.

    Trump favors casting light on the factors behind high healthcare costs, wants to import drugs from other countries and allow Medicare to directly negotiate on drug prices—all measures that could theoretically bring prices down, but efforts that are opposed by the drug lobby.

    In fact, Proposition 61, a California ballot initiative that ties the prices state agencies pay for prescription drugs to the discounts negotiated by the U.S. Veterans Affairs Department, drew more than $100 million in spending from opponents, most of it from the pharmaceutical industry. The measure failed.

    On Wednesday morning, the CEO of Pharmaceutical Research and Manufacturers of America said the lobbying group looks forward to working with the next Congress and Trump administration.

    “We are in a new era of medicine with treatments and cures that are completely transforming the fight against debilitating diseases,” PhRMA CEO Steve Ubl said. “To ensure this innovation continues, we need to modernize the FDA to keep pace with scientific advances, remove regulatory barriers that make it harder to move to a value-driven healthcare system and focus on making better use of the medicines we have today."

    Blair Childs, senior vice president of public affairs for group purchasing organization Premier, believes that a curb on drug pricing will ultimately come from a speedier FDA approval process or a shortening of patent exclusivity, and not direct regulatory action or executive pressure. But Congress will need to address exorbitant healthcare spending and Republicans need to understand the role of GPOs in that process, Childs said.

    “Republicans are firm advocates for competition and choice, and GPOs are really built on the notion of competition and choice,” Childs said. The biggest critics of the GPO industry tend to be Democrats, including Sen. Richard Blumenthal (D-Conn.), who says GPOs influence healthcare costs. He was re-elected to a six-year term Tuesday.

    Under a Trump presidency, drugmakers and devicemakers alike are hoping for a more nimble FDA and an overall political climate that is, in their words, “pro-innovation.” Trump's promise to repeal the medical-device tax is more-than-welcome news for the Advanced Medical Technology Association, the devicemaker lobby known as AdvaMed, though its CEO maintained in a statement that the issues at hand have always been “bipartisan issues.”

    “The medical technology community stands ready to work with President Trump, his administration and the new Congress on pro-innovation policy solutions to address the healthcare challenges facing the country and to ensure all Americans have timely access to the latest medical technologies, devices and diagnostics,” said Scott Whitaker, AdvaMed's president and CEO.

    FDA policies and regulations could be influenced by whether FDA Commissioner Robert Califf decides to stay on with a Trump administration. Experts say he should be able to transition smoothly into a Republican administration that supports speeding up the agency's processes.

    "It wouldn't surprise me if Califf stuck around. I think it's a job he wants to have,” said Jim Shehan, head of Lowenstein Sandler's FDA regulatory practice.

    But ultimately there are many unknowns for the medical manufacturing industry, said Shehan, a former FDA official and former general counsel for drugmaker Novo Nordisk. Trump didn't campaign as pro-industry, but rather said that he'd fight for the working American. The healthcare leaders he appoints will be key to gauging the future of his presidency, experts agree.

    “There's no one who has a lot of insight into what Trump's thoughts and policies will be on drug industry-specific issues,” Shehan said. “If someone tells you that they do, they're just lying.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    congress prescription drugs
    PBMs, Big Pharma face off in House hearing
    Biden COVID copy_i_i.jpg
    Biden administration asks employers to help more workers who lose Medicaid
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing